Impact of aggressive therapy in patients with non-small cell lung carcinoma presenting with brain-only oligometastatic disease.
Phillip J. Gray
No relevant relationships to disclose
David Sher
No relevant relationships to disclose
Beow Y. Yeap
No relevant relationships to disclose
Sarah K Cryer
No relevant relationships to disclose
Raymond H. Mak
No relevant relationships to disclose
Stephanie E. Weiss
No relevant relationships to disclose
Brian Michael Alexander
No relevant relationships to disclose
David Michael Jackman
Consultant or Advisory Role - Foundation Medicine; Genentech; Infinity
Honoraria - Chugai Pharma